Condition
    Effectiveness 1/5

    DIM for Hormonal Acne

    DIM is widely promoted for hormonal acne on the basis of its effect on oestrogen metabolite ratios. No randomised trial has tested it for acne, and its enzyme-inducing activity may reduce the effectiveness of hormonal contraception — often the very treatment that is working.

    Overview

    DIM is widely promoted for hormonal acne on the basis of its effect on oestrogen metabolite ratios. No randomised trial has tested it for acne, and its enzyme-inducing activity may reduce the effectiveness of hormonal contraception — often the very treatment that is working.

    Verdict

    Insufficient evidence

    No controlled trial evidence in acne. The oestrogen metabolism shift is real; the skin benefit is unproven and the contraceptive interaction is a genuine concern.

    How It Works

    DIM induces CYP1A1 via the aryl hydrocarbon receptor, shifting oestradiol metabolism toward 2-hydroxyoestrone, and shows weak androgen receptor antagonism. Since acne is driven principally by androgen action on the sebaceous gland, a modest anti-androgenic effect is the plausible route — but it has never been quantified in skin.

    Dosing & Protocol

    Typical dose

    Recommended dose
    100-200 mg/day of microencapsulated DIM with food
    Expected timeframe
    Unknown; 8-12 weeks would be a reasonable self-trial window

    Protocol

    timing
    With food
    starting dose
    100 mg/day with a fat-containing meal
    typical range
    100-200 mg/day
    assessment point
    12 weeks; stop if no change

    Evidence

    What the studies say

    There are no randomised controlled trials of DIM for acne of any subtype. The supporting evidence consists of biomarker studies showing reliable urinary 2-hydroxy to 16-alpha-hydroxy oestrone ratio shifts at 100-300 mg/day, cell culture work showing androgen receptor antagonism at concentrations above achievable plasma levels, and clinical trials in unrelated indications — chiefly cervical intraepithelial neoplasia, where results were largely null. Extrapolating from a urinary metabolite ratio to a clinical skin outcome is the exact inferential step that the literature does not support.

    No studies are yet linked to both DIM and Hormonal Acne.

    Safety

    Caveats

    DIM induces cytochrome enzymes and may reduce hormonal contraceptive efficacy — a serious consideration for the population most likely to try it. Some users report an initial symptom flare.

    Less likely to help if

    Anyone whose acne is primarily non-hormonal, and anyone relying on hormonal contraception for either acne control or pregnancy prevention.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.